Ross Clark

Ross Clark

Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. He writes on Substack, at Ross on Why?

Covid’s knock-on effect on child deaths

From our UK edition

The daily death toll has been a constant backdrop to the Covid-19 crisis. Would we ever have entered lockdown, would so many people have been driven to panic, were it not for the publication, every afternoon, of the number of deaths in the past 24 hours? It has helped set in the minds of the public the idea that this is a lethal disease, on a scale completely removed from other common diseases. How much differently would we see Covid-19, though, if we were also fed with a slightly different statistic: the number of indirect deaths, caused not by the disease itself but by other factors associated with lockdowns: closure of medical facilities, fear of going to a hospital and so on.

Why are some people being repeatedly tested for coronavirus?

From our UK edition

Testing, the government keeps telling us, is the way out of the coronavirus lockdown. Soon, the Prime Minister assured us in his address to the nation last Sunday, we will be testing 'literally hundreds of thousands of people every day'. Given that Matt Hancock seems finally to have achieved his ambition of testing 100,000 people day – as he promised to achieve by the end of April – who could doubt that the PM will realise his promise? True, there was some controversy over the way that the health secretary reached his 100,000 tests on the very last day of April, by counting tests which had been put in the post. The numbers of tests performed then fell back in subsequent days.

Could having a cold protect against Covid?

From our UK edition

Could having a common cold protect you against Covid-19? The intriguing prospect has been raised by a team from the La Jolla Institute for Immunology in California. They were researching the response of human T cells – which play a vital role in the immune system – in patients who have recovered from Covid-19. The response they detected, however, also showed up in 40 to 60 per cent of a control group that had not been exposed to Covid-19. In a paper published in the journal Cell they write: 'This may be reflective of some degree of crossreactive, pre-existing immunity to Sars-CoV-2 in some, but not all, individuals'. Sars-CoV-2 is the virus which causes Covid-19.

This study from Iceland suggests reopening schools is safe

From our UK edition

Some countries are refusing to open their schools for fear of a prompting a second wave of coronavirus infections. But their policies would appear to be flatly contradicted by evidence from Iceland. There, a company called deCODE Genetics, in association with the country’s directorate of health and the national university hospital, has analysed the results of coronavirus tests on 36,500 people. The tests identified 1801 cases of people suffering from the disease – and ten deaths. Each case was carefully tracked. In not a single case could the researchers find evidence of a child passing on the disease to their parents. The company’s CEO, Kari Stefansson, revealed the findings in an interview carried on the Science Museum website.

Are we seeing 2000 excess deaths a week from non-coronavirus causes?

From our UK edition

Cambridge professor of the public understanding of risk David Spiegelhalter recently made the point that, given the uncertainties over exactly what constitutes a death from coronavirus, the number we should we watching is the ONS’s figure for deaths from all causes. That, he argued, will give us the surest indication as to the progress of the epidemic. For anyone minded to take his advice, the ONS’s figure for deaths from all causes fell again in the week ending 1 May for the second week running. In England and Wales, 17,953 deaths were registered, down from 21,997 in the week ending 24 April and 22,351 in the week ending 17 April.

How do we know which lockdown measures should be lifted first?

From our UK edition

Today, the cabinet has to decide where to go next with the lockdown – although the decision will not be announced until Sunday. Boris Johnson has talked of a ‘menu of options’ for relaxing some of the measures, but we have been warned not to expect too much. The government has also distanced itself from speculation that rules on outdoor exercise will be loosened, as well as garden centres and a few other businesses allowed to reopen. How does anyone know which lockdown measures have been effective and which haven’t? A team of epidemiologists led by Paul Hunter have attempted to do that, and their pre-published paper may well feed into the government’s decision-making today.

Israel’s antibody breakthrough

From our UK edition

The Israeli government is reporting this morning that the country’s Institute for Biological Research has made a breakthrough in the development of a potential treatment against SARS-CoV-2, the virus which causes Covid-19. Scientists there have isolated a ‘monoclonal neutralising antibody’ which could potentially neutralise the virus after infection. The antibody was obtained from the blood of an infected patient. It is called monoclonal because it is generated from a single cell – which could allow vast quantities of the antibody to be produced quickly. Is it the breakthrough that could make all the difference? Treatment of novel viruses with monoclonal neutralising antibodies has been under development for some time, notably for Ebola, SARS and MERS.

Herd immunity may only need 10-20 per cent of people to be infected

From our UK edition

Since mid-March there has been an assumption that herd immunity against Covid-19 would not be achieved until around 60 per cent of the population has been infected. It is a figure which gave rise to the now-famous paper by Professor Neil Ferguson of Imperial College, which claimed that a herd immunity policy (which the government denies ever following) would result in the deaths of 250,000 people in Britain. That figure has been challenged by scientists who have questioned some of the assumptions behind it – for example, it assumed a mortality rate of 0.9 per cent which Imperial College itself has since revised downwards to 0.66 per cent, and some believe is lower still. But today comes another challenge.

Have we been fighting a very different disease to China?

From our UK edition

One of the great mysteries of coronavirus is how the epidemic has become much more severe in Europe and North America than in the Far East. A disease which appeared to be on the wane in China, South Korea and elsewhere in mid-February suddenly erupted with a vengeance in Europe in March, with death tolls quickly surpassing those in Wuhan. Various explanations have been offered: from the Chinese lying about the extent of cases and deaths to the difficulties of enforcing lockdowns and launching intrusive tracking and tracing strategies in western democracies. But then have we really been fighting the same disease?

Coronavirus reinfection fears appear to be unfounded

From our UK edition

A week ago, the World Health Organisation (WHO) issued a warning which, if it were true, would constitute the most depressing-yet development in the story of Covid-19. It said that there was ‘no evidence’ that people who have already been infected with the disease, and who have developed antibodies as a result, have gained any immunity from further infection. The warning seemed to tally with news from South Korea that 263 people who had already had the disease appeared to have become re-infected. If antibodies to SARS-CoV-2 – the virus which causes Covid-19 – do not prevent you from further infection it would suggest that we could never develop herd immunity from the disease. Moreover, waiting for a vaccine is likely to prove a fruitless exercise.

Could Remdesivir eliminate the need for a coronavirus vaccine?

From our UK edition

Over the past few weeks the government’s scientific advisers have indicated that the only real way out of the coronavirus crisis is a vaccine – until then a high degree of social distancing will have to remain. Given that no-one expects a vaccine to be ready for deployment for another year at the very earliest, this would have very serious implications for the economy, and for society at large. But there is another possible route out of social distancing – not so good, but possibly available a lot more quickly. This is for an effective therapeutic drug to emerge. It would not stop anyone contracting the virus but could improve the prospects for those who do catch it.

How New Zealand won its fight with coronavirus

From our UK edition

A milestone was reached today when New Zealand became the first country to declare that all community transmission of coronavirus has effectively ceased. We have previously seen China (whose figures are not universally trusted), South Korea and Vietnam wrestle their figures for new cases of the disease down to very low levels, but New Zealand’s Prime Minister Jacinda Ardern has been the first national leader brave enough to use the word ‘eliminated’ – although she did prefix that with the word ‘currently’. New Zealand has had 1,469 cases of the disease and 19 deaths. At four deaths per million, this works out at a small fraction of Britain’s 305 deaths per million. So what has been New Zealand’s secret?

Britain can’t rely on a vaccine to ease lockdown restrictions

From our UK edition

Six weeks ago Britain stood as a bit of an outlier among western countries in that our government seemed set to manage, rather than suppress, coronavirus. It rejected the idea that it was pursuing ‘herd immunity,’ but seemed to do just that. Now we stand out for a different reason: we are the only country which appears to be committing itself to remain in lockdown, or close approximation thereof, until a vaccine arrives. In much of Europe, lockdown restrictions are tentatively being relaxed as infection rates and death rates fall. Here, ministers tell us it is far too early for that sort of thing – we will need restrictions on our lives, in one form or another, until we have a vaccine available. Is that a plausible strategy?

Could this antibody test offer a route out of lockdown?

From our UK edition

Finally, the government is to start antibody tests to see how prevalent infection with the SARS-CoV-2 virus – which causes Covid-19 – is among the general population. Over the next few days, testing kits are being sent to 20,000 randomly-selected households. The results will be crucial because it will inform us how effective lockdown has been – and whether there is any point in continuing with that policy. If, say, five per cent showed signs of having had the virus it would mean that the epidemic potentially had a long way yet to run. If 50 per cent have been infected with the virus it would mean that lockdown has failed and was pointless in any case – we would already be on the verge of herd immunity. So what will be the result?

What will happen to your savings after coronavirus?

From our UK edition

What joy it has been to have some cash over the past two months. For gamblers, to be sure, there have been opportunities to take advantage of a volatile stock market (and even more opportunities to get it wrong and lose a packet). But cash is cash – it just sits there holding its value, without having to watch the markets with dread every day. Well, certainly over the short term. But history teaches us a painful lesson in these circumstances: while investing in stock markets is full of sorrows, investing in cash offers few pleasures. It is ordinary savers ultimately who were made to pay for the economic crisis of 2008/09, and doubtless it will be they who are made to pay for this crisis, too. Cash hasn’t been all that steady over the past two months, in any case.

Is the lockdown costing lives?

From our UK edition

Over the next few weeks we are likely to start hearing more and more about a growing death toll – not the one from Covid-19 but the one from other conditions. Disturbingly, it appears to be rising, and we are going to have to start asking what role the lockdown has played in this. In its latest release on weekly deaths in England and Wales, released this morning, the Office for National Statistics reveals that there were 18,516 deaths in the week ending 10 April. That is 7,996 more than the five-year average for deaths in this particular week of the year. However, in only 6,213 cases was Covid-19 recorded as a cause. In other words, there were around 1,700 extra deaths from causes other than Covid-19. What were they caused by?

Is Covid-19 more widespread – and less deadly – than we thought?

From our UK edition

Last week I reported here a Stanford University study which found that infection with SARS-CoV-2 – the virus which causes Covid-19 – could be over 50 times as widespread in one Californian county than official figures suggested. Now comes yet another piece of evidence suggesting similarly huge under-reporting of cases. Researchers from Massachusetts General Hospital performed antibody tests on 200 random members of the public they found on the streets of Chelsea, near Boston. They discovered that 32 per cent of them had antibodies suggesting they had already been infected with the virus – official figures show that just 2 per cent of the local population had been confirmed to be suffering from the virus.

Will Sweden’s social distancing-lite work?

From our UK edition

The science of epidemiology relies a lot on modelling because, for obvious reasons, controlled experimentation would be unethical. But in the case of Covid-19 we do have something approaching a real-life experiment – in that Sweden has declined to follow other European countries into lockdown. Instead, it has followed a policy which might be summed up as social distancing-lite. Gatherings of more than 50 people have been outlawed, closing theatres and putting an end to sports events. But children up to the age of 16 are still attending school, shops and restaurants are still open – albeit with rules preventing people standing up at the bar – and no police officer is to blow a whistle at you for sitting on a park bench.

Stanford study suggests Covid infections are 50 to 85 times more than confirmed cases

From our UK edition

Another day, and yet more evidence has appeared that could indicate the number of people who have been infected with SARS-CoV-2, the virus which causes Covid-19, might be vastly higher than official figures suggest. This time a Californian study suggests the figure in one county could be more than 50 times the number who knew they had had the virus. A team from Stanford university and other US universities recruited volunteers in Santa Clara County via Facebook adverts and produced a sample of 3000 representatives of the county as a whole. They were then invited for blood tests to detect the presence of antibodies to the virus. The result was positive in 1.5 per cent of cases. Adjusting for age, gender and ethnicity the results suggest that 2.

Leaked US document suggests Covid may be less lethal but more widespread

From our UK edition

Have we been vastly underestimating the number of people who have been infected with Covid-19 and correspondingly overestimating its mortality? No one knows because we don’t know just how widespread this infection is in the population at large. But a leaked document from the US Department of Homeland Security suggests that the US government, at least, is working on the assumption that the virus is a lot harder to contain – but a lot less deadly – than is widely assumed. The document compares the likely outcome of two scenarios: one in which the outbreak is ‘unmitigated’ – i.e. life carries on as normal – and one in which the government imposes a 30-day 'shelter in place' order followed by further mitigation measures.